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Bacteria are an enormous and largely untapped reservoir of biosensing proteins. We describe
an approach to identify and isolate bacterial allosteric transcription factors (aTFs) that
recognize a target analyte and to develop these TFs into biosensor devices. Our approach
utilizes a combination of genomic screens and functional assays to identify and isolate
biosensing TFs, and a quantum-dot Förster Resonance Energy Transfer (FRET) strategy for
transducing analyte recognition into real-time quantitative measurements. We use this
approach to identify a progesterone-sensing bacterial aTF and to develop this TF into an
optical sensor for progesterone. The sensor detects progesterone in artificial urine with
sufficient sensitivity and specificity for clinical use, while being compatible with an inex-
pensive and portable electronic reader for point-of-care applications. Our results provide
proof-of-concept for a paradigm of microbially-derived biosensors adaptable to inexpensive,
real-time sensor devices.
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B iosensors underlie applications ranging from medicaldiagnostics, environmental monitoring, food and watersafety, to the detection of chemical or biological threats1. A
typical biosensor utilizes a biorecognition element coupled to a
transduction mechanism2,3. Yet the number and types of bior-
ecognition elements are limited. The gold standard for clinical
hormone analysis uses antibodies as the biorecognition element
which are expensive to design and manufacture, do not provide
an intrinsic read-out, and do not readily support repeated or
continuous measurements.
Bacteria have evolved over 3 billion years to detect and respond
to a wide range of stimuli4–13. One common molecular sensing
mechanism is an allosteric transcription factor (aTF). Binding of
ligand to aTFs leads to differential binding of the TF to its cognate
DNA binding sites and an alteration in gene expression. Allosteric
TFs are used as biosensors in whole cell applications14, but the use
of bacterial cells in sensors is limited by slow response times, bio-
safety concerns, and the practical limitations of using a cellular
host15. Moreover, characterized TFs are a small fraction of the
hundreds of thousands of known TFs that have been sequenced10,
and sequenced genes are only a tiny sampling of the diversity of
microbes16. Here, we report an approach to identify and harvest
microbial aTFs specific to a target analyte, and a transduction
strategy for engineering these into sensor devices. We show the
application of our approach to develop an optical progesterone
sensor based on a previously uncharacterized microbial aTF iden-
tified with our screening approach.
Results
A progesterone sensing aTF. Our screening approach employs a
combination of genomic and functional assays for the targeted
identification, validation, and characterization of TF biosensors
for specific analytes (Supplementary Fig. 1). Our approach
(Supplementary Fig. 1) is based on three observations: bacterial
TFs commonly bind upstream of their genes to regulate their own
promoters or those of adjacent genes17–21, genes for the meta-
bolism of analytes are often found in genome clusters22, and these
clusters are often induced by their substrates via TFs in genomic
proximity23–26. We applied our approach to identify bacterial
aTFs responsive to steroid hormones owing to their central roles
in human physiology, wellness, and health. Steroids are also
found widely in nature due to contamination by human activity
and natural production by plants, fungi, and animals27. Conse-
quently a host of environmental bacteria are able to use steroids
as carbon and energy sources28. One steroid metabolizing bac-
terium is Pimelobacter simplex (also Nocardioides simplex and
formerly Corynebacterium simplex) which biotransforms a range
of steroids29,30. Though P. simplex is employed in industry for the
metabolism of steroids31, little is known about the corresponding
regulatory mechanisms.
P. simplex was screened to identify aTFs capable of sensing
steroid hormones. Cultures of P. simplex were exposed to
aldosterone, cortisol, estrone, estradiol, progesterone and control
media (Supplementary Fig. 2). RNA Sequencing (RNA-Seq) was
used to identify gene clusters and associated TFs induced by
steroids (Fig. 1). One such gene cluster was significantly
upregulated on exposure to progesterone, aldosterone, and
cortisol and was termed the Steroid Responsive Genomic Island
(SRGI). (Fig. 1a–e, Supplementary Table 1). No differential
expression of this cluster was observed for estrone or estradiol
(Supplementary Table 1). The SRGI overlaps a previously
reported cluster of genes experimentally associated with steroid
metabolism29,32 and includes one annotated 3-ketosteroid-9-α-
hydroxylase, two annotated 3-ketosteroid-δ1-dehydrogenases,
and one annotated steroid δ-isomerase (Supplementary Table 1).
Importantly, the SRGI includes three predicted but functionally
uncharacterized TF genes29 (Fig. 1f, Supplementary Table 1): (1)
a predicted TetR-family TF in a divergent promoter with a
predicted ketosteroid-dehydrogenase gene, (2) a predicted IclR-
family TF adjacent to a second ketosteroid-dehydrogenase gene,
and (3) a predicted MarR-family TF upstream of the IclR-TF.
Only the first two TFs (whose proteins were termed SRTF1 and
SRTF2, respectively) display induction by sterols in our
experiments (Fig. 1f). Analysis of the divergent intergenic region
upstream of the SRTF1 gene revealed a 22 bp palindromic
sequence immediately upstream of the adjacent ketosteroid-
dehydrogenase gene (Fig. 1h). We confirmed binding to this
palindrome by SRTF1 using a method for in vitro chromatin-
immunoprecipitation followed by sequencing (in vitro ChIP-Seq).
In vitro ChIP-Seq discovered two additional binding sites in the
cluster including one upstream of SRTF2 (Supplementary Fig. 3).
These data suggest that SRTF1 mediates the steroid responsive-
ness of both ketosteroid-dehydrogenase genes and SRTF2. We
thus focused additional analysis on SRTF1.
We quantitatively confirmed that SRTF1 is a sterol responsive
aTF using biolayer interferometry (BLI)33 (Fig. 2). Synthetic
oligonucleotides containing either the predicted palindromic site
found upstream of SRTF1 or a shuffled control sequence were
conjugated to the BLI probe (Fig. 2a). The probe was placed in a
solution with purified SRTF1 protein and no steroids. SRTF1
rapidly bound to the oligo containing the predicted binding
sequence, while no binding was observed to the scrambled
sequence, further confirming the specificity of the predicted binding
motif (Fig. 2a). The probe was then moved into a solution with no
protein and either vehicle or 5 μM steroid hormones (Fig. 2a, b, d).
Minimal unbinding was observed with vehicle, and a quantitative
analysis indicated nanomolar affinity of SRTF1 to the oligonucleo-
tide in the absence of sterols (Supplementary Fig. 8, Supplementary
Table 2). In contrast, SRTF1 rapidly dissociated after exposure to
progesterone, with 81% dissociation at 30 s after exposure
compared to 4.5% in vehicle (Fig. 2d, e). This change in DNA
binding was highly specific to progesterone. Exposure to cholesterol
or the estrogens beta-estradiol or estrone resulted in no SRTF1
dissociation relative to control, while exposure to aldosterone or
cortisol yielded only 10 and 13% dissociation, respectively (Fig. 2d,
e). Moreover, no differences in dissociation were observed after
exposure to 5β-Pregnane-3α,20-α-diol (pregnanediol) and
5β-Pregnane-3α,20-α-diol-glucuronide (pregnanediol-glucuronide)
(Fig. 2d, e). Both are urine metabolites of progesterone34, and
antibodies against pregnanediol-glucuronide are the basis of many
tests for the indirect measurement of progesterone35. Experiments
with varying concentrations of progesterone demonstrated that
progesterone-induced dissociation was dose-dependent (Fig. 2b, c).
Together, these data confirm that SRTF1 is an aTF that binds its
cognate DNA site in the absence of sterol hormones and
allosterically rapidly unbinds in the presence of progesterone. To
our knowledge, this is the first example of a progesterone-sensing
bacterial transcription factor.
A QD-TF-FRET framework for aTF biosensors. Using aTFs as
an affinity-based biorecognition element in a biosensor requires
converting analyte binding into a detectable signal. Antibodies are
the benchmark for affinity-based biosensors3. However, anti-
bodies bound to an analyte are inert. Detection of binding typi-
cally requires the addition of secondary antibodies, and this
additional step prevents real-time and continuous measurements
and prohibits multiple measurements3. In contrast, aTFs combine
affinity recognition with a built-in mechanism for the real-time
transduction of reversible analyte binding: the reversible binding
to their cognate DNA binding sites.
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Fig. 1 Screening of P. simplex for steroid sensing aTFs. a–e Log2-fold change expression in response to each hormone relative to control. Each triangle is a
gene (red= differentially expressed TF, black= non-differentially expressed TF, blue= gene with annotated sterol related function, green= differentially
expressed other gene, gray= non-differentially expressed other gene). The Steroid Responsive Gene Island (SRGI) that is differentially expressed in
response to PRG, ALD, and CRT is boxed in red. SRTF1 and SRTF2 are two steroid responsive TFs. f Zoomed in view of SRGI. Yellow peaks are
experimentally validated binding sites for SRTF1. g SRGI region around SRTF1. h SRTF1 palindromic binding site upstream of SRTF1 gene. RNA-seq data are














































































Fig. 2 SRTF confirmed as a progesterone responsive aTF. a Top panel: BioLayer Interferometry (BLI) experimental approach. Bottom panel, binding layer
thickness on probe normalized to baseline. Probes were loaded with oligos containing the SRTF1 binding site (red line) or a scrambled sequence (gray line).
Addition of progesterone resulted in rapid unbinding of SRTF1 (red line) that was not observed with vehicle control (cyan line). b Unbinding of SRTF1 is
dose-responsive. Dissociation curves in duplicate were normalized such that binding at time 0 was equal to 1. c Fraction SRTF1:DNA complex from curves
shown in panel b dissociated at 5 s. d Dissociation curves in triplicate of SRTF1 in the presence of 5 μM various steroids showing strongest induction by
progesterone normalized as in panel b. e Fraction SRTF1:DNA complex from curves shown in panel d dissociated at 30 s. Error bars are standard error over
three experiments. Data underlying bar graphs in panels c and e are available in the Source Data file.
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We have developed a framework for coupling the molecular
transduction mechanism of aTFs to an optical output (Fig. 3a).
Importantly, this approach can be used to develop optical
biosensors with any aTF for which a cognate binding site is
known. Our framework uses QD-TF-FRET. Quantum dots are
widely used in bioimaging and biosensing and provide high
photostability, color tunability, and abundant surface area for
biofunctionalization36. In our approach, QD FRET donors are
decorated with purified TFs and a DNA oligonucleotide with
the TF binding site is conjugated to a FRET acceptor. TF-
hormone binding alters TF-DNA binding resulting in changes
in fluorescence. When TFs are bound to the DNA probe, the
donor and acceptors are close enough to enable energy transfer.
FRET reduces the emission intensity from the QD (donor
fluorescence intensity, FD) and increases emission intensity
from the acceptor (acceptor fluorescence intensity, FA, Fig. 3b).
When TFs are not bound to the DNA probe FRET is reduced
leading to increased FD and decreased FA. Sensor output is a
normalized ratio of acceptor to donor emission and measuring
this ratio increases signal relative to either FA of FD alone. We
describe here the comprehensive characterization and
validation of this framework through the development of a
QD-TF-FRET biosensor.
An optical progesterone biosensor. We used our QD-TF-FRET
framework to develop an optical biosensor for progesterone based
on SRTF1. Specifically, CdSe/CdS/ZnS QDs were coated via a
biphasic ligand exchange with a zwitterionic polymer containing
histamine groups for chelation-based binding to the QD sur-
face37. The SRTF1 gene was cloned with a C-terminal 6x His-tag,
purified, and self-assembled onto the QD surface at specified
average ratios of TFs to QD. Oligonucleotides containing SRTF1
binding sites were labeled with Cy5 as the FRET acceptor and
combined with QD-TFs at specified ratios of DNA to QD. The
QD emission spectrum overlapped the Cy5 excitation spectrum
to enable FRET (Supplementary Fig. 4).
As a first sensor test (sensor 1), oligonucleotides containing the
strong SRTF1 binding site upstream of the SRTF1 promoter were
used. SRTF1 was combined with QDs at a ratio of 4 TFs per QD
and oligonucleotides were combined with QD-TFs at a ratio of 18
oligos per QD. The fluorescence emission of QD-TF/DNA in
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Fig. 3 Development and validation of an optical progesterone biosensor. a Biosensor scheme. b FRET occurs when TFs are bound to DNA resulting
in less donor emission and increased acceptor (FA). Sensor output is a normalized ratio of acceptor to donor emission. Fi= isofluorescence point.
c Progesterone sensor response. Sensor 1, sensor 2, and sensor 3 described in text. d Cross-reactivity to related steroids using sensor 3 with SRFT1 (cross-
hatched) and SRTF1_MUT1 (solid). e Repeated cycles of progesterone exposure using sensor 3. f Reproducibility of different manufactured batches. Batch a
and b are derived from 2 different batches of QDs two SRTF1 purifications. g Storage stability of sensor 3 in the dark: room temperature (RT), 4 °C, or
lyophilized and stored at −20 °C or at RT. h Sensor 3 in artificial urine: artificial urine (containing PRG) added at RT or at 37 °C or sensor lyophilized
recovered in artificial urine and PRG added in artificial urine. Sensor 3 at RT-1 was tested at 10 different PRG conditions. The fit is of the curve (blue line) is
only for this sensor output. Sensors 3 at RT-2, RT-3, 37 °C and freeze-dry were measured at 5 different PRG concentrations. c, f, h Error bars are standard
errors over three experiments. Data for reported means in panels c, e, f, g, and h are available in the Source Data file.
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aqueous solution was immediately measured, using a plate reader,
as a function of varying concentrations of progesterone. We
observed a clear and reproducible dose-dependent decrease in
sensor response with increasing progesterone (Fig. 3c), corre-
sponding to progressive unbinding of SRTF1 from the oligonu-
cleotide and decreased FRET. This sensor response was observed
as quickly as it could be measured. As a negative control, we
tested the same sensor configuration with an oligonucleotide
containing a scrambled binding site and no response was
observed (Supplementary Fig. 5). The response of sensor 1
exhibited a broad linear range over more than a log of
progesterone concentrations. A fit to a Hill function produced
an IC50 of 738 nM and a LOD of 53 nM (Supplementary Table 3).
Sensor 1 thus demonstrated proof-of-concept for a quantitative
progesterone sensor based on a newly characterized bacterial aTF.
While sensor 1 was capable of detecting progesterone at
nanomolar levels, we sought to improve this sensitivity. The QD-
TF-FRET framework provides several parameters and alternative
configurations for sensor optimization (Supplementary Fig. 6).
An initial analysis identified three key parameters governing
sensitivity. First, as expected, the affinity of the aTF for the
analyte is one parameter. Second, consistent with previous
reports38, our modeling predicted that altering the affinity of
the aTF to the oligo would modulate overall sensor sensitivity,
with decreasing oligo affinity resulting in increasing overall
sensitivity to analyte (Supplementary Fig. 6). This parameter is
readily modified in our sensor strategy by altering the aTF
binding site. This parameter is not available to antibody-based
affinity sensors. Third, we predicted that altering the ratio of TFs
conjugated to QDs could improve sensitivity. This is consistent
with reports demonstrating that decreasing the density of
antibodies bound to particles improves the sensitivity of
immunoassays39.
We used these predictions to develop progesterone sensors
with improved sensitivity. First, we modified the oligonucleotide
to contain a binding site with 2 mutated bases in one half of the
palindrome to generate sensor 2 (Supplementary Fig. 7). BLI
confirmed the lower affinity of SRTF1 to this modified sequence
(Supplementary Table 2, Supplementary Fig. 8). As predicted, this
resulted in a sensor with substantially improved sensitivity with
an IC50 of 133 nM and an LOD of 35 nM (Fig. 3, Supplementary
Table 3, Supplementary Fig. 5). We then modified sensor 2 to
create sensor 3 by decreasing the ratio of TFs to QD to 1:1 while
maintaining the 18:1 ratio of oligonucleotides to QD-TF
complexes. This further improved sensitivity to an IC50 57 nM
and an LOD of 15 nM (Fig. 3, Supplementary Table 3,
Supplementary Fig. 5). Sensor 3 also displays an expanded linear
range over nearly two logs of progesterone concentration. While
we anticipate further improvements to sensitivity with additional
tuning of parameters these initial changes result in an order of
magnitude increase in sensitivity sufficient to detect progesterone
levels in urine and plasma of pre-menopausal women (Supple-
mentary Table 4)40.
BLI characterization of SRTF1 indicated that our sensor would
exhibit specificity to progesterone. We confirmed this by testing the
cross-reactivity of sensor 3 to structurally and physiologically
related compounds. As expected, no sensor response was observed
when the sensor was exposed to either cholesterol or estrone
(Fig. 3d, Supplementary Fig. 9). We also tested our sensor against
pregnanediol, which is highly structurally similar to progesterone
(Supplementary Fig. 2), and pregnanediol-glucuronide. Again, no
cross-reactivity was observed to either metabolite (Fig. 3d,
Supplementary Fig. 9). Our sensor is thus a direct sensor of
progesterone. Consistent with the BLI results, we observed 36%
cross-reactivity to cortisol, and 18% cross-reactivity to aldosterone
(Fig. 3d, Supplementary Table 5, Supplementary Fig. 9).
Published reports have demonstrated the ability to dramatically
alter the specificity profile of aTFs with a combination of random
mutagenesis, directed evolution, and targeted protein modifica-
tions41. These methods can be used to further increase the
specificity of SRTF1-based sensors to progesterone. Thus, we have
generated a mutant library of SRTF1. As a first step in
characterizing this library, 10 mutants were randomly selected
and characterized with a reporter gene assay (Supplementary
Fig. 10). One mutant, SRTF1_MUT1, demonstrated a relative
decrease in sensitivity to cortisol. Sequencing of the
SRTF1_MUT1 gene revealed two mutations located in a region
of SRTF1 with the potential to contain the steroid binding
domain (Supplementary Fig. 11). We constructed a version of
sensor 3 using SRTF1_MUT1 and characterized its response to
the panel of steroids. Remarkably, we observed a 6-fold decrease
in cross-reactivity to cortisol of 5.7%, with no change in cross-
reactivity to other tested sterols (Fig. 3d, Supplementary Table 5,
Supplementary Fig. 12). While only preliminary, and based on a
randomly selected handful of mutants, these results suggest that
directed evolution can further improve both the specificity and
sensitivity of SRTF1 to progesterone.
A key advantage of aTF sensors relative to antibodies is the
potential for multiple and continuous measurements. This stems
from the fact that no secondary assays are required that result in
fixation of analyte binding. All interactions associated with the
QD-TF-FRET sensor are reversible. As an initial demonstration
of this capability, we tested sensors with repeated cycles of
progesterone exposure and removal by overnight dialysis
(Supplementary Fig. 13). Measurements were performed after
each exposure and dialysis. The results confirm that repeated
exposures to the same progesterone concentration resulted in
nearly identical sensor output (Fig. 3e, Supplementary Fig. 14).
While greater variability was observed between measurements
after dialysis, this was likely due to limitations in the ability of
dialysis to completely remove progesterone. These data confirm
the ability of our sensor to reliably measure repeat exposures of
progesterone without the need for surface immobilization or
additional procedures to reverse binding.
The development of practical devices requires manufacturing
and storage reproducibility. To assess this, we tested three
independent sensor batches constructed over the span of
6 months. In addition, the sensors were developed from two
independent purifications of SRTF1, and a QD with a modified
surface treatment and emission spectrum was used for the third
sensor batch. As shown in Fig. 3f, the sensor responses to
progesterone for all three batches were identical. We further
tested the stability of our sensors to storage in different
conditions: room temperature, at 4 °C, and at room temperature
after freeze-drying for up to a week. In all cases, we observed
consistent responses when sensors were retrieved or rehydrated at
all tested progesterone concentrations (Fig. 3g, Supplementary
Fig. 15). We also tested long-term storage for ten months after
freeze-drying. Rehydration restored full sensor responsiveness
(Supplementary Fig. 15) although altered dose-response char-
acteristics would necessitate re-calibration. These results are
consistent with reports demonstrating the stability of cell-free
gene circuits containing transcription factors for over a year15.
Point-of-care urine testing. Progesterone sensing has applications
in fertility planning. The detection of surges in luteinizing hormone
(LH) and the rise in estrogen prior to the LH surge predict but do
not verify ovulation42. Detecting progesterone surges confirms
ovulation but typically requires blood testing34,43,44. Two at-home
urine tests are currently being marketed43,45 to measure
pregnanediol-glucuronide. However, pregnanediol-glucuronide
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levels are more variable than progesterone levels, and up to 12% of
women do not metabolize progesterone sufficiently to produce
detectable amounts34. To our knowledge, no urine test for the direct
detection of progesterone is available. As a first test of our sensor for
urine testing, we measured responses to varying concentrations of
progesterone in artificial urine. We tested three different conditions
using sensor 3: artificial urine at room temperature, artificial urine
warmed to body temperature, and sensors freeze-dried and then
rehydrated in artificial urine at room temperature. In all cases, we
see responses identical to buffer, verifying that common interferents
in urine do not affect the sensing of progesterone by the sensor
(Fig. 3h).
Use of our sensor at home or at point of care requires a
portable electronic reader. As proof-of-principle, we built a
prototype device using inexpensive off-the-shelf detection
electronics (Fig. 4a, Supplementary Fig. 16). A 10 mW UV LED
controlled by an Arduino was used for excitation. Two
phototransistors amplified using a standard low-voltage common
emitter circuit detected fluorescence emissions. A 600 nm
bandpass filter was used to isolate QD fluorescence emission
while a 665 nm long pass filter was used to isolate Cy5 emission
(Supplementary Fig. 16). Despite its simplicity, tests of the
progesterone sensor in this low-cost device confirmed the same
degree of sensor accuracy as with a state-of-the-art laboratory
plate reader (Fig. 4b). This proof-of-principle device can be
reduced in size and cost through printed circuit board fabrication
for the electronics and 3D printing for the housing. Any similar
device could be used for low-cost sensing with any bacterial aTF
sensor developed with the QD-TF-FRET optical biosensor
framework.
Discussion
Together, our data provide the first demonstration of a microbial
screening-to-sensor approach to develop new sensing devices for
specific target analytes. The progesterone sensor provides proof-
of-concept for a class of sensors based on bacterial aTFs. It
demonstrates sensitivity, reproducibility, stability, and signal
strength applicable for point-of-care use. It also possesses two key
advantages over current antibody-based assays. First, the intrinsic
transduction mechanism of aTFs enables real-time and repeat
sensing. Our QD-TF-FRET framework converts this transduction
to an optical readout. Methods for converting this transduction
into a direct electrical readout could also be developed. Second,
bacterial proteins are inexpensive to produce, modify, and evolve.
The specificity of the progesterone sensor could be further
improved through directed evolution41, also providing an
opportunity to evolve variants specific to other steroids. More
broadly, the identification of a progesterone sensing aTF high-
lights the diverse and largely untapped reservoir of biorecognition
elements latent within bacteria. To more fully capture this
diversity, our approach can be extended to uncharacterized and
unculturable organisms with metagenomic screening12, and
expanded to target other biorecognition elements, including
redox enzymes for electrochemical sensors1,46,47. Our results thus
provide a paradigm for the targeted development of a diverse
range of sensor devices.
Methods
Materials. All DNA oligonucleotides were purchased from IDT Technologies.
Progesterone (PRG), cholesterol (CHL), cortisol (CRT), aldosterone (ALD), estrone
(ESN), 5β-pregnane-3ɑ,20-ɑ-diol (PRE), 5β-pregnane-3ɑ,20-ɑ-diol-glucuronide
(PRE-Glu), and lysozyme were bought from Sigma Aldrich. Artificial urine DIN
EN1616:199 was bought from Pickering Laboratories. RNAprotect Bacteria
Reagent was bought from Qiagen. Proteinase K was bought from Roche.
Cadmium oxide (CdO; 99.95%, Alfa Aesar), sulfur (99.95%, ACROS Organics),
1-octadecene (ODE; 90% ACROS Organics), and oleylamine (80–90%) were
bought from Fisher Scientific and used as purchased. Zinc acetate (Zn(Ac)2,
99.99%), selenium pellets (Se, 99.99%), trioctylphosphine (TOP, 97%),
trioctylphosphine oxide (TOPO, 99%), oleic acid (OA, 90%), poly(isobutylene-alt-
maleic anhydride)–6000 g mol−1 (PIMA), (2-aminoethyl)trimethylammonium
chloride, histamine, triethylamine, and HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) were obtained from Sigma-Aldrich. HPLC-grade
solvents including hexanes (Fisher Scientific), methanol (Honeywell), anhydrous
dimethyl sulfoxide (Sigma Aldrich) and chloroform (J.T. Baker) were bought and
used without further purification. HEPES 1× is a solution of 25 mM of HEPES and
150 mM of NaCl, adjusted to pH 7.6.
Strain selection. Pimelobacter simplex strain 6946 was purchased from ATCC and
referenced with a corresponding GenBank accession number (CP009896.1). The
strain is an obligate aerobe and was grown in media and conditions as recom-
mended by ATCC.
Strain characterization. To determine the doubling time of the strain, growth
curves were generated (Supplementary Fig. 18). All growth curves were done in
100 µL per well volumes in 96 well flat clear bottom black polystyrene TC-treated
microplates which were individually wrapped with a lid and sterile (Corning).
Measurements were done by an Infinite M200 Pro (TECAN) spectrophotometer at
the temperature suited for P. simplex. Readings were performed over 96 cycles of
15 min each at 600 nm absorbance with 25 flashes in a 3 × 3 (XY-Line) type reads
per well. In between reads there was orbital shaking at 150 rpm frequency for a
total of 10 min. To first characterize the growth alone, a ½ serial dilution of 9




















































Fig. 4 Low-cost portable reader. Proof-of-concept device demonstrating point-of-care use built using inexpensive off-the-shelf electronics. a Exploded
view of device. The sensor is excited by a UV LED. Filters are used to isolate QD and Cy5 fluorescence emissions, which are then detected by two
phototransistors. Scale bar= 42mm. Full schematic in Supplementary Material. b Sensor accuracy using the low-cost prototype device matches accuracy
using a high-end plate-reader. Error bars are standard errors over three experiments. Data for reported means in panel B are available in the Source Data
file. CAD files for panel a cage plate, LED mount, fiber adapter plates, and cuvette holder were purchased from Thorlabs.
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Then each concentration was measured as previously described by the TECAN
microplate reader and normalized against a media background control in technical
triplicate.
Solvent exposure. Once an appropriate starting cell concentration was chosen, a
secondary growth curve was performed to test the toxicity levels of the solvents
used to dissolve steroids of interest (Supplementary Fig. 18). Since the steroids used
are heavily hydrophobic, they often need to be dissolved in organic solvents such as
DMSO or ethanol which are toxic to bacteria at high concentrations. P. simplex was
incubated under microplate reader conditions previously mentioned at a starting
OD determined by the first growth curve with DMSO, ethanol, or H20 at ½ serial
dilutions for a total of eight concentrations (50–0.39%) tested in technical triplicate.
Two controls were included per solvent; a positive control without solvent and a
media control which allowed for appropriate normalization. Solvent exposure
growth curves allowed for choosing the maximum amount of solvent concentration
that strains would sustain while maintaining relative viability in order to determine
a range of steroid concentrations which could be used.
Steroid exposure. A tertiary growth curve was performed to test the toxicity levels
of steroid specific to P. simplex (Supplementary Fig. 18). The strain was incubated
under microplate reader conditions previously mentioned at a starting OD
determined by the first growth curve and the highest solvent concentration cor-
responding to the steroid of interest with steroid at ½ serial dilutions for a total of
seven concentrations tested in singlet. Testosterone, progesterone, 17β-estradiol,
hydrocortisone, and aldosterone were all dissolved in ethanol while estrone was
dissolved in DMSO. Three controls were included for each steroid; a positive
control with the highest tolerable solvent concentration (%), a positive control with
media, and a media control which allowed for normalization. Steroid exposure
growth curves allowed for choosing the maximum amount of steroid concentration
that P. simplex would sustain while maintaining relative viability.
RNA extraction. Cells were grown in 6 mL volumes of media at the OD, solvent,
and steroid concentrations found from the growth curves in 14 mL polypropylene
round-bottom tubes. The same controls as in the steroid exposure growth curve
were used for setting up RNA extraction samples. The cells were incubated at their
corresponding temperature with continuous orbital shaking at 150 rpm until mid-
log phase and the beginning of stationary phase from the start of inoculation.
Afterward, samples were removed and a 1:1 ratio of RNAprotect Bacteria Reagent
was added followed by spinning down at 4 °C for 10 min at 4000 × g. Supernatant
was removed and the pellet re-suspended in 300 µL of RNAprotect and transferred
into 2.0 mL Safe-Lock Tubes. The samples were then spun down once again at 4 °C
for 10 min at 10,000 × g. Once the supernatant has been removed the samples were
placed on ice and ready for RNA extraction. RNA extraction was done by Qiacube
set to the RNeasy Protect Bacteria Mini Kit protocol of bacterial cell pellet with
enzymatic lysis. Tube A was prepared as described except with the addition of
150 mgmL−1 lysozyme and 20 mgmL−1 proteinase K all diluted in 1× TE buffer.
RNA samples were subsequently quantified using Qubit RNA HS Assay Kit
(Thermo Fisher Scientific) and analyzed using a RNA 6000 Pico Kit (Agilent) in a
2100 Bioanalyzer (Agilent). RNA samples were either immediately used for RNA-
Seq library preparation or stored long-term at −80 °C.
RNA-Seq library preparation. After RNA samples have been quantified and
analyzed they were DNase treated using a TURBO DNase 2 U µL−1 (Thermo
Fisher Scientific) and cleaned using Agencourt RNAClean XP SPRI beads (Beck-
man Coulter). RNA-Seq libraries were then produced from these samples using a
slightly modified ScriptSeq v2 RNA-Seq Library Preparation Kit (Illumina)
ensuring use of unique index primers through ScriptSeq Index PCR Primers (Sets
1–4) 48 rxns/set (Illumina). Libraries were quantified by both a Qubit dsDNA HS
Assay Kit (Thermo Fisher Scientific) and by High Sensitivity DNA Kit (Agilent).
The resulting molarity was then used to determine at what concentration samples
should be pooled to (either 1, 2, or 4 nM). After a desired pooling concentration
was chosen, the samples were diluted to that particular molarity and 2 µL of each
sample dilution was added into a single tube and submitted to the Boston Uni-
versity Microarray and Sequencing Resource Core Facility. Whole transcriptome
RNA sequencing was performed by a NextSeq 500 (Illumina) at high output
(400M reads) with 75 bp paired end sequencing read length. The data was then
analyzed in-house through a proprietary Galagan Lab pipeline.
RNA-Seq data analysis. Adapter sequences were removed from reads and low
quality bases trimmed from both ends using Cutadapt48. Reads were aligned to the
reference genome with Bowtie249. BAM files were sorted and indexed using
Samtools50. Transcript assembly and expression quantification was performed
using Cufflinks51. All resulting raw expression counts were normalized as a group
using deseq52. A custom matlab script was then used to calculate fold changes of
normalized counts for each gene between each sterol exposure experiment and its
corresponding vehicle control.
Protein expression and purification. SRTF1 coding sequence codon-optimized
for expression in Escherichia coli was ordered from Integrated DNA technologies
with appropriate up-stream and down-stream fusion sequences for cloning into the
pRham C-His Kan vector (Lucigen), resuspended in 1× TE buffer, and 45 ng heat
shock transformed into chemically competent E. cloni 10 G (Lucigen) along with
25 ng of linearized pRham C-His Kan Vector (Lucigen). Cells were grown on LB
agar+ 50 µg mL−1 kanamycin overnight at 37 °C. Resulting colonies were grown in
5 mL LB+ kanamycin, plasmid purified using Qiagen Miniprep Kit, and CDS
insertion verified through Sanger Sequencing using forward primer rRham F and
reverse primer pEtite R (Lucigen).
Protein was expressed in E. cloni 10 G cells grown overnight from a singly
colony. Five milliliters overnight LB+ kanamycin culture was diluted in 250 mL of
fresh LB+ kanamycin, then allowed to grow to an OD600 of approximately
0.6 shaking at 37 °C. Two and a half milliliters of filter sterilized 20% w/v rhamnose
was then added to induce protein expression, and culture was shaken for 4 h at
37 °C. Culture was removed then removed from the incubator and stored at 4 °C
overnight. Culture was then pelleted by centrifugation and frozen overnight.
Protein was purified using the Ni-NTA Fast Start kit (Qiagen). Cells were lysed
using 10 mL of the provided Native Lysis Buffer supplemented with 10 mg
lysozyme and 250 U benzonase as specified in the manufacturer’s protocol. Pellet
was resuspended by stirring and pipetting up and down with a 25 mL graduated
pipette. Cells were lysed on ice for 1 h, with gentle swirling every 20 min. Some
preparations were highly viscous after the 1 h incubation, likely due to incomplete
nuclease activity. Viscous lysates had an additional 250 U benzonase added to them
and were incubated for twenty more minutes. All samples treated with additional
benzonase had their viscosity reduced to normal after this additional incubation.
Lysate was centrifuged at 14,000 × g for 30 min at 4 °C. Lysate supernatant was
applied to a pre-drained Ni-NTA column and allowed to run through at room
temperature. Column was washed three times with 4 mL of 3 mL of Native Wash
Buffer (NEB), then eluted twice with 1 mL each of Elution Buffer (NEB).
Protein was present in both elution fractions off the column, so elutions 1 and 2
were pooled for desalting. Protein was either dialyzed against the destination buffer
using 0.5–3 mL 3500 MWCO Slide-a-Lyzer (ThermoFisher), twice for 2 h at room
temperature with magnetic stirring, then overnight at 4 °C without stirring, or
using Amicon Ultra-0.5 centrifugal filters with a 10 kDaMW cutoff. Elutions were
added to the column 0.5 mL at a time, spun at 14,000 × g at 4 °C until only
approximately 75 µL remained, around 30 min. Destination buffer was added to the
0.5 mL mark, and centrifugation repeated. This process was repeated 3 additional
times, for a total of 4 times.
Destination buffer for protein used in BLI, iv-ChIP-seq, and QD-TF-FRET
assays was Tris-buffered saline pH 7.4. Protein concentration was quantified using
a Qubit Protein Assay kit (ThermoFisher), then aliquoted and frozen at −80 °C
until used.
In vitro ChIP-Seq. We developed an in vitro ChIP-Seq assay similar to previously
published in-vitro DNA precipitation protocosl53,54. P. simplex picked from a
single colony on M3 Agar was grown in M3 Broth at room temperature with gentle
shaking for 3 days until culture was turbid. One milliliter aliquots of culture were
pelleted and genomic DNA was extracted using the GenElute Bacterial Genomic
DNA kit (Sigma-Aldrich) using the included Gram-Positive Lysis solution and
associated protocol adjustments for Gram positive bacteria. Purified gDNA was
sheared into approximately 200 bp fragments in 130 μL aliquots using a Covaris
S2 sonicator using a duty cycle of 20%, an intensity of 5, 200 cycles per burst, a time
of 60 s, and 12 total cycles.
Purification of fragments of an appropriate size was done using AgenCourt
AmpPure XP beads. 1.8× volume of bead slurry was added to the sonicated DNA
and mixed by pipetting, followed by a five-minute incubation at room temperature.
The DNA/slurry mixture was then placed on a magnetic rack for 10 min until all
beads were pulled to the side of the tube. Supernatant was aspirated, and beads
were washed twice with 200 μL 70% ethanol while still on the magnetic rack. Beads
were air dried for 10 min, then resuspended in 100 μL of water, mixed by pipetting,
and incubated at room temperature for 10 min. Beads were pulled down by placing
on a magnetic rack for 10 min, then the supernatant and eluted DNA was pipetted
off and saved. Fragment length was confirmed through 1% agarose gel
electrophoresis in 1× TBE.
Fifty nanogram of sheared DNA was mixed with 500 ng purified SRTF1-CHis
to a final volume of 500 μL in 1× IPP150 (10 mM Tris-HCl pH 8.0, 150 mM NaCl,
0.1% NP40). Mock ChIP reactions were done by omitting the purified protein.
Mixture was incubated at room temperature for 1 h, then 3 μL of 6×-His Tag
Monoclonal Antibody His.H8 (Thermofisher Scientific) was added. Mixture was
then incubated at 4 °C overnight with rocking.
Incubated mixture was then mixed with 5 μL of Protein G agarose beads (Pierce)
that had been washed with 1mL of IPP150 and pelleted by centrifugation for 2min at
2000 × g. Bead mixture was incubated on a rocking platform for half an hour at 4 °C,
then an hour and a half at room temperature. Beads were washed 3 times with 1mL
of IPP150, mixed by rocking each time. Wash buffer was removed by pelleting beads
at 2000 × g for 2min and pipetting off supernatant. DNA was eluted by adding 150 μL
of “Elution From Beads” buffer (50mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS) to
pelleted beads and incubating at 65 °C for 15min. Elution was repeated with a 5min
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65 °C incubation. Elutions were pooled, then purified using a QIAquick PCR
Purification Kit (Qiagen), eluting with 30 μL of buffer EB.
Barcode adapters were ligated to immunoprecipitated DNA using the NEBNext
Ultra II DNA Library Prep Kit for Illumina. As starting gDNA had been pre-
sheared before immunoprecipitation, size selection was performed after 10 cycles of
PCR barcoding. Library size and integrity was validated with an Agilent DNA 1000
Kit on an Agilent Bioanalyzer.
Library was sequenced on an Illumina NextSeq 500 to a depth of 4–10M reads
per sample. Illumina adapter sequences were removed with Cutadapt, and reads
were aligned to the P. simplex VKM Ac-2033D genome CP009896.1 using Bowtie2.
BioLayer interferometry. Single stranded DNA oligos containing SRTF1 binding
sites or control sequences were ordered from IDT. Forward strands with 5′ biotin
were annealed to reverse strands by mixing to a final concentration of 10 µM in
Annealing Buffer (10 mM Tris-HCl pH 8.0, 50 mM NaCl), heating to 95 °C, then
slowly letting them cool to room temperature.
All BLI steps were performed in 1× BLI Buffer (28 mM Tris-HCl pH 8.0, 5 mM
MgCl, 4.25% Glycerol, 25 mM NaCl, 1.67 mgmL−1 BSA) at 30 °C in a ForteBio
OctetRed96. For DNA association assays, SA tips were baselined in buffer, then
dsDNA was loaded on by dipping into wells containing 75 nM DNA in buffer.
DNA-coated tips were baselined again in buffer, then dipped in buffer containing
varying concentrations of SRTF1 and allowed to reach equilibrium. Tips were then
dipped in buffer for complex dissociation. Dissociation of DNA from the tip was
controlled by subtracting the trace from a DNA-coated tip that was not exposed to
SRTF1. Trace Y-Axes were aligned to the last 5 s of the second baseline step, and
noise removed by Savitzsky-Golay filtering. Association and dissociation data were
fit to a Mass Transport model.
Hormone-induced dissociation was assayed using BLI by dipping DNA-coated
SA tips in buffer containing 150 nM SRTF1 and allowing the reaction to reach
equilibrium. Complex was dipped in buffer containing varying amounts of
hormone. Curve traces for each sensor were rescaled such that the binding level at
equilibrium was equal to 1.
Quantum dots synthesis. Core/shell/shell quantum dots were made using our
previously reported procedure55 and is described briefly here. The precursors used
for this synthesis included: 0.2 MCd(OA)2, 0.2 M Zn(OA)2, 0.2 M sulfur in ODE,
and 1M TOP:Se. For the sulfur and selenium precursors, the appropriate amount
of anion was weighed and dissolved into either ODE or TOP at the desired con-
centration with gentle heating. Once the solutions were fully dissolved, the pre-
cursors were heated under vacuum at 120 °C for at least 1 h before use to remove
traces of water. For Cd(OA)2 and Zn(OA)2, CdO or Zn(Ac)2 were weighed and
added to oleic acid at a 1:4 molar ratio. The solutions were heated under vacuum at
120 °C until fully dissolved and diluted to a final concentration of 0.2 M with ODE.
All precursors were stored under argon at room temperature. Both Cd(OA)2 and
Zn(OA)2 are waxy solids at room temperature and were therefore heated to 120 °C
for use in the QD synthesis.
For nucleation of CdSe cores, we used an air-free hot injection method. In brief,
1 g of TOPO, 8 mL of ODE, and 1.9 mL of 0.2 M Cd(OA)2 were loaded into a
100 mL round bottom flask (rbf) and placed under vacuum at room temperature
for 30 min. The flask was heated to 80 °C and degassed by backfilling with argon
and switching back to vacuum 3× over the course of 1 h. Once the solution had
been sufficiently degassed, the flask was placed under active argon flow and heated
to 300 °C. In an argon-filled glovebox, we pre-mixed 4 mL of 1M TOP:Se, 3 mL of
oleylamine, and 1 mL of ODE for injection into the Cd solution at 300 °C. The
reaction temperature was set to 270 °C. After 3 mins, the flask was taken off of the
heating element and allowed to cool to room temperature. The CdSe cores were
precipitated from solution under air-free conditions using ethanol and methanol
and re-dispersed in hexanes.
For shelling, a successive ion layer adsorption reaction (SILAR) was used as
previously described. In brief, 5 mL ODE and 5mL oleylamine were added to a
100 mL rbf and heated under vacuum at 120 °C for 1 hr before 200 nmol of CdSe
cores in hexanes were added to the flask, and the hexanes removed via low-pressure
evaporation. For each shell material, a single monolayer, defined by the lattice
constant of each material, was added at a time. The amount of precursor needed to
add each monolayer was calculated on a volume basis using the density and lattice
constants for wurtzite CdS and ZnS. For the CdS shell, 1 monolayer of CdS was
added. The first Cd addition was added dropwise at 160 °C to the core solution
under argon and annealed for 2.5 h. The temperature was then increased to 240 °C
and the corresponding amount of sulfur precursor added dropwise and annealed
for 1 h. All additional monolayers were added and annealed at 240 °C. After CdS
shelling, 2 monolayers of ZnS were added in a similar fashion. After 2 full
monolayers of ZnS were added, an additional layer of Zn was added to ensure that
the QD surface was Zn-rich.
Polymer synthesis. The polymer capping the QDs (P1) was synthesized using a
slightly modified version of a previously reported procedure56. In a typical experi-
ment, 180mg of PIMA (poly(isobutylene-alt-maleic anhydride), 6000 gmol−1,
0.03mmol, 1 equivalent) was dissolved in 3mL anhydrous dimethyl sulfoxide at
45 °C. In parallel, 116mg (2-aminoethyl)trimethylammonium chloride (0.66 mmol,
22 equivalents), 73mg histamine (0.66mmol, 22 equivalents), and 193 µL triethy-
lamine (1.39 mmol, 46 equivalents) were dissolved in 1.5 mL anhydrous dimethyl
sulfoxide at 50 °C. After complete dissolution of both solutions, the solution con-
taining the amines was added with a syringe to the PIMA solution. The reaction was
kept overnight at 45 °C. The polymer was purified by several precipitations in ethyl
acetate. A white powder was obtained with 67% yield. 1 H NMR (500MHz, D2O):
δ(ppm)= 8.33 (s, 0.35 H, imidazole), 7.14 (s, 0.52 H, imidazole), 3.61 (0.63H), 3.37
(2.24H), 3.08 (s, 5.14 H, quaternary amine), 2.82 (1.13 H), 2.49 (1.26 H), 2.15
(1.01H), 2–1 (m, 2.45 H), 0.86 (m, 6 H, 2CH3). FTIR shows the disappearance of the
C=O stretch band of the anhydride at 1770 cm−1 and appearance of the C=O
stretch of carboxylic acid and amide bond at 1710 cm−1 and1650 cm−1, respectively.
Ligand exchange. QDs were transferred into water by capping their surface with
the polymer P1. In a typical experiment, 475 µL QDs ([QD]= 3.0 µM, 1.4 nmol)
were dissolved in 600 µL of chloroform. In parallel, 560 µL of P1 at 10 mgmL−1 in
DMSO was diluted in 560 µL chloroform. The solution of P1 was added to the QD
dispersion and the reaction proceeded overnight with vigorous stirring. The next
day, 0.5 mL of 0.1 M NaOH was added and the dispersion quickly shaken by hand.
The QDs nicely transferred to the upper water phase. The water phase was
extracted and centrifuged at 3800 × g for 1 min. Then the supernatant was filtered
through 100 nm PVDF and washed 3 times with 0.1 M NaHCO3 with a 100k ultra-
centrifugal filter. QDs were recovered in 0.1 M NaHCO3 at a concentration around
5 µM.
Sensor assembly. For a typical experiment, using a molar ratio of QD/TF/DNA=
1/4/18: 275 µL QDs at 0.15 µM in 1× HEPES with 1% BSA, were mixed with 275 µL
SRTF1-his6 at 0.6 µM in 1× HEPES, at room temperature for 45 min. Double-
stranded DNA labeled with a Cy5 fluorescent probe at the 3′ and 5′ ends (275 µL,
2.7 µM in 1× HEPES,) was added to the mixture. After 30 min, 220 µL of
1× HEPES, and 330 µL of 5× binding buffer (25 mM MgCl2, 25% glycerol, and
250 mg L−1 Invitrogen™ UltraPure™ Salmon Sperm DNA in 0.1 M Tris-HCl) were
added and the mixture incubated for 15 min at RT.
Plate reader measurements. Fluorescence measurements were recorded on a
Horiba Nanolog spectrofluorometer equipped with a plate reader. Absorption
spectra were recorded using a Nanodrop 2000c. Fifty microliter of the sensor (QD/
TF/DNA) was split in 3 × 9 centrifuge tubes to which 10 µL of progesterone at the
desired concentration is added. As such, the final concentration of QD/TF/DNA
for the measurements is 25 nM/100 nM/450 nM. A 384-well plate was filled with
60 µL of each solution. The fluorescence intensity was monitored on a spectro-
fluorimeter from 535 nm to 800 nm with excitation at 400 nm and a 450 nm long-
pass filter before the emission detector. Fluorescence intensity was spectrally
deconvolved into FRET donor and acceptor components and total intensity used to
calculate normalized FA/FD. Ratiometric analysis using single wavelength point
measurements of FA and FD displayed equivalent accuracy to full deconvolution.
Stability assays. For the stability assays, QDs, TF, and DNA were mixed together
and stored in the conditions described (e.g., RT, at 4 °C, or in the freezer following
lyophilization); in each case the sensors were protected from light to prevent
photobleaching. HEPES 1× and 5× binding buffers were added to the sensor
components before starting the progesterone titration. Lyophilized sensors were
first recovered in ultra-pure water (same volume as sublimated during lyophili-
zation process), then HEPES 1× and 5× binding buffer were added before the
progesterone titration.
Cross reactivity calculation. Cross-reactivity is calculated with the following
equation57:
%Cross reactivity ¼ IC50of analyte
IC50of cross  reactant
Cross-reactivity assays were performed using the sensor 3 configuration in HEPES
1× with SRTF1 and the mutant SRTF1_MUT1.
Limit of detection calculation. The detection limit is the smallest concentration or
absolute amount of analyte that has a signal significantly larger than the signal
arising from a reagent blank. Mathematically, the limit of detection in the signal
domain (LD) is given by:
LD ¼ meanblank  3:3 ´ σtest
where meanblank is the mean signal for a reagent blank and σtest is the pool standard








where σi is the standard deviation in signal intensities for n replicates of the ith test
concentration, with a total of m different test concentrations.
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The limit of detection (LOD) was calculated using the parameters of the fit with
the non-linear equation for y= LD:






The 95% Confidence Interval was calculated using Origin Pro Software.
Artificial urine assays. Artificial urine composition: pH 6.6 ± 0.1, urea
25.0 g L−1, sodium chloride 9.0 g L−1, disodium hydrogen orthophosphate
anhydrous 2.5 g L−1, potassium dihydrogen orthophosphate 2.5 g L−1, ammo-
nium chloride 3.0 g L−1, creatinine 2.0 g L−1, sodium sulfite hydrated 3.0 g L−1.
For the artificial urine assays, QDs, TF, and DNA were mixed together in 1×
HEPES before artificial urine and artificial urine+ PRG was added such that 50%
of the final volume comprised artificial urine.
Artificial urine at 37 °C: the sensor was assembled at RT then artificial urine and
artificial urine+ PRG were added at 37 °C.
For tests in artificial urine following lyophilization, QDs, TF and DNA were
assembled in 1% BSA for QDs and ultra-pure water (no salts) and lyophilized. The
sensor was recovered in artificial urine (same volume as sublimated during
lyophilization process). Then artificial urine+ PRG was added to the sensor.
Portable electronic reader. A UV-LED (LED405E, 10 mW, Thorlabs) was
attached to an SM1-threaded LED mount (S1LEDM, Thorlabs) that was screwed
into one of the ports of the cuvette holder. The LED was powered with 3.3 V using
an Arduino Uno. Two phototransistors (Digi-Key, 751-1057-ND) were used to
detect the emitted light, one for each channel. In order to detect the Cy5 emission
(670 nm), a 665 nm LP filter (Chromatech, ET655lp) was placed in front of one of
the phototransistors to filter the light emitted by the Cy5 dye. In order to detect the
QD emission (605 nm), a 600 nm BP filter (Edmund Optics, P/N 84785, 600 nm,
FWHM 50 nm) was placed in front of the second phototransistor to filter the light
emitted by the QDs.
Each one of the phototransistors was placed in a common-emitter
phototransistor circuit (Supplementary Fig. 16). A DC power supply was used to
power the circuit (Bk Precision, 1760A). During an experiment, the voltage drop
across the phototransistor was monitored with a multimeter (Agilent34410A) that
was connected to LabView, which enabled real-time recording of measurements.
The device was enclosed in a metal Faraday cage.
The LED was turned on and allowed to warm up for at least 20 min prior to the
experiment. One hundred microliter of sensor with a given concentration of
progesterone was pipetted into the cuvette. The cuvette was inserted into the
cuvette holder such that the 10 mm path length was parallel to the filters. Upon
inserting the cuvette, a timer was started. A black cover was placed over the cuvette
and a lid placed on the Faraday cage. At t= 10, 30 and 50 s, a Labview program
was started to begin data collection for a duration of 10 s each. Each 10 s long
period of data collection is counted as one technical replicate.







QDsignal;c;i ¼ 5 Vout;cy5;i
 
Cy5signal;c;i ¼ 5 Vout;QD;i
 
c= the concentration of progesterone in the sample i= the replicate number for a
given concentration (i.e., 1 is the first technical replicate, etc.)










In order to calculate the error bars associated with the average of the Ratio, the













Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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